BioSpace News Archive

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and neuro-degenerative disorders and certain cancers, today announced has been added as a member of the broad-market Russell Microcap Index

Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced an oral poster presentation of Phase 2 study results of Avexitide in congenital hyperinsulinism (HI) at the American Diabetes Association (ADA) 81st Scientific Session.

Felix Biotechnology today announced the initiation of a research project with Biocogent, the leading provider of high technology products and services to the personal care and cosmetic industries.

Lineage Cell Therapeutics Joins Russell 3000 ® and Russell Microcap ® Indexes

Senseonics Holdings, Inc. today announced further presentation of PROMISE Study data evaluating the next generation Eversense CGM System at the American Diabetes Association Virtual 81st Annual Scientific Sessions.

Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and Bioeq AG (“Bioeq”) today announced that they have entered into a strategic partnership for the exclusive commercialization of Bioeq’s FYB201, a biosimilar candidate to Lucentis ®.

Moderna , Inc. today announced that Kate Cronin will join Moderna as Chief Brand Officer effective Monday, July 12, 2021.

Cybin Inc. Releases Annual Financials and Provides Business Highlights

REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing CoSci-REMD Bio (“Cosci‑REMD Bio”), today announced positive top-line results from a phase 2 clinical program of volagidemab (“Vola”) in patients with type 1 diabetes were presented at the American Diabetes Associations (ADA) 81st Scientific Session

The report highlights the trends prevalent in the global healthcare mobility solutions market and the factors driving the market along with those that act as deterrents to its growth.